USD 786.53 million
Lymphedema Treatment Market Size, Share, Growth Analysis, By End-User(Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others), By Product(Compression Bandages, Compression Stockings, Pneumatic Compression Devices, Others), By Condition Type(Cancer, Cardiovascular Diseases, Inflammatory Diseases, Others), By Treatment Type(Compression Therapy, Surgery, Drug Therapy, Laser Therapy), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35G2213 |
Region:
Global |
Published Date: February, 2024
Pages:
165
|Tables:
122
|Figures:
79
Lymphedema Treatment Market Insights
Lymphedema Treatment Market size was valued at USD 860.14 Million in 2023 and is poised to grow from USD 941.85 Million in 2024 to USD 1900.22 Million by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).
Lymphedema is a disorder characterized by abnormal bodily swelling brought on by lymphocytosis due to lymphatic system dysfunction. 90% of the time, it affects the lower extremity, 10% the upper extremity, and 1% the genitalia. The infection brought on by the parasite Wuchereria bancrofti is the most frequent cause of lymphedema (filariasis). One of the most dreaded and unfortunate side effects of breast cancer treatment is lymphedema. A National Center for Biotechnology Information (NCBI) report states that 40% of women receiving treatment for breast cancer had lymphedema. The increasing incidence of breast cancer, the rising prevalence of lymphedema, the launch of several new products by major market players, and the rising demand for effective goods as a result of technical improvements are the main drivers of the lymphedema treatment market expansion.
According to the United States Department of Health and Human Services, lymphedema, which affects lymph node draining, can develop in cancer patients either at the beginning of the disease or after therapy. For instance, it has been observed that it might happen right away or up to 30 years following breast cancer therapy. In addition, 80% of patients exhibit beginning within 3 years following surgery, with the other 20% developing edema at a 1% per year pace. In addition, a sizable patient population, mostly women, experience lower-limb lymphedema following the management of gynecologic cancer, with vulvar cancer survivors having the highest frequency (37%) and ovarian cancer survivors having the lowest prevalence (7%). Additionally, two years after surgery, the overall incidence of arm lymphedema ranged from 8% to 56%. The American College of Surgeons Oncology Group (ACOSOG) Alliance Z 1071 longitudinal substudy reports that patients in breast cancer trials report a 3-year cumulative incidence of arm edema and arm heaviness. Options for cancer therapy that are very successful and cutting edge help to reduce the likelihood of lymphedema. As a result, the market's key players for cancer therapies are putting a lot of effort into introducing new products.
US Lymphedema Treatment Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Hospitals
Fastest Growth
Hospitals
Growth Rate
9.5% CAGR
Global Lymphedema Treatment Market 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)
To get more reports on the above market click here to Buy The Report
Lymphedema Treatment Market Segmental Analysis
Global lymphedema treatment market has been segmented based on end-user, product, type, route of administration, age group, affected area, and region.
Based on end-user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. Based on product, the market is segmented into compression bandages, compression stockings, pneumatic compression devices, others. Based on affected area, the market is segmented into Genital, Lower Extremity, Upper Extremity and Others. Based on age group, the market is segmented into adult and geriatric. Based on route of administration, the market is segmented into Oral, Injectable and Others. Based on type, the market is segmented into primary and secondary lymphedema. Based on condition type, the market is segmented into cancer, cardiovascular diseases, inflammatory diseases, and others. Based on treatment type, the market is segmented into Compression Therapy, Surgery, Drug Therapy, Laser Therapy, and Others. Based on region, the global market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Lymphedema Treatment Market Analysis by End-User
The hospital sector is predicted to have the most revenue share in 2021 and dominate the market throughout the projection period. The significant number of patients who come directly to the hospital for Lymphedema diagnosis and treatment is driving the segment growth.
In addition, it is projected that the segment's expansion will be fueled by the increased acceptance of less invasive procedures combined with novel and advanced therapies. Additionally, the segment is anticipated to experience significant growth potential due to the rising number of hospitals providing Lymphedema treatments in emerging nations.
During the forecast period, the specialty clinics segment is expected to have the highest CAGR. The fact that Lymphedema treatment is mostly provided in specialist units or centers can be blamed for the segment's rapid expansion. Specialty clinics with a separate section for treating lymphedema perform specialized surgical therapies such as debulking and liposuction. Additionally, the expansion of specialist clinics across the globe is predicted to accelerate market expansion.
Global Lymphedema Treatment Market by End-Users, 2021 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Lymphedema Treatment Market Regional Insights
North America held the largest market share in 2021 due to the region's rapidly developing technological breakthroughs in the healthcare industry. Additionally, there is likely to be a tonne of potential for market expansion due to the increased awareness of IgG4-related disorders. Additionally, the market is anticipated to be led by the rising prevalence of lymphedema in nations like the U.S. and Canada as a result of rising breast cancer rates in those nations. For example, the Lymphatic Education & Research Network estimates that about 10 million Americans experience lymphedema and other lymphatic illnesses. These illnesses affect more individuals in the US than multiple sclerosis, muscular dystrophy, Parkinson's disease, and AIDS combined.
The Asia Pacific region is anticipated to have the highest market share during the forecast period. This expansion can be attributed to the rising incidence of chronic diseases, improvements in the healthcare system, and an increase in government and pharmaceutical company R&D efforts to create lymphedema treatment strategies. Faster growth in emerging economies like India and China is anticipated to benefit the expansion of the lymphedema treatment market. Due to rising disposable income, China is dominating the Asia-Pacific market.
Europe is expected to have the second-largest market share during the forecast period. The lymphedema treatment market in this region is projected to rise as a result of leading industry participants' cooperation initiatives and the development of new products. Additionally, the increased incidence of lymphedema contributes to the market expansion in the region. For instance, the NHS estimates that 200,000 people in the UK experience lymphedema each year.
Global Lymphedema Treatment Market By Geography, 2021 - 2028
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Lymphedema Treatment Market Dynamics
Lymphedema Treatment Market Driver
- The lymphedema treatment market is anticipated to develop as a result of increase in lymphedema and breast cancer cases. It is projected that the prevalence of cancer cases will increase, opening up enormous market expansion prospects. Healthcare facilities are increasingly needed as a result of rising health spending and growing investments in drug discovery research and development. Additionally, during the anticipated period, advancements in novel lymphedema treatment solutions are anticipated to fuel market expansion.
- Technological advancements in lymphedema treatment strategies are anticipated to hasten the market expansion in the coming years. In addition, the government's beneficial programs and the reimbursement standards are probably advantageous to market expansion.
Lymphedema Treatment Market Restraint
- Although technology has advanced, there is still no permanent cure for lymphedema, which is expected to restrain market expansion.
- It is predicted that the high cost of procedures and treatments will impede market expansion.
Request Free Customization of this report to help us to meet your business objectives.
Lymphedema Treatment Market Competitive Landscape
Very few companies compete in the global lymphedema treatment market, but many of them could employ various growth tactics to keep their position in the market as a whole. To expand and surpass some of their rivals in the global lymphedema treatment market, the smaller players in the market would look for funding from private investors. In the upcoming years, lymphedema treatment market companies may use R&D as a key growth strategy. For instance, In May 2021, AIROS® Medical Inc., a medical technology manufacturer specializing in compression therapy products, announced the launch of AIROS 6 Sequential Compression Therapy devices and Arm Plus garments soon after it was granted multiple regulatory approvals by the U.S. Food and Drug Administration (FDA).
Top Players in the Global Lymphedema Treatment Market
- Bio Compression Systems
- Tactile Medical
- Medi
- Lympha Press
- Sigvaris
- BSN Medical
- L&R USA Inc.
- Devon Medical Products
- 3M Health Care
- JOBST USA
- Thuasne
- Wright Therapy Products
- BioHorizons IPH, Inc.
- Haddenham Healthcare
- ArjoHuntleigh
- Paul Hartmann
- Bioventus
- Baxter International Inc.
- CircAid Medical Products, Inc.
- Essity Aktiebolag
Lymphedema Treatment Market Recent Development
- In October 2023, a working group led by A Cornell revealed the surprising mechanisms behind lymphedema. In a breakthrough that could revolutionize atherosclerosis therapy, the Cornell-led collaboration successfully created a 3D in-vitro model of a functional human nervous system.
- In June 2023, The EMA approved a new device called Lymphapress for the treatment of lymphedema. Lymphapress uses compressed air to reduce inflammation.
Lymphedema Treatment Key Market Trends
- The lymphedema treatment market is expected to expand as more people become affected by the condition. Additionally, as the disease spreads more widely, inventive and cutting-edge remedies are being created at an exponential rate to reduce risk during therapy. Additionally, it is anticipated that rising healthcare spending will fuel industry expansion, along with a rise in healthcare innovation. Additionally, the introduction of innovative medical equipment by pharmaceutical firms is promoting business expansion globally.
Lymphedema Treatment Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected using Primary Exploratory Research backed by robust Secondary Desk research.
According to our analysis, by end-user, hospitals dominated the global lymphedema treatment market in 2021 and are anticipated to maintain their dominance throughout the forecast period. In 2021, North America dominated the global lymphedema treatment market owing to the region's rapidly developing technical breakthroughs in the healthcare industry.
| Report Metric | Details |
|---|---|
| Market size value in 2019 | USD 786.53 million |
| Market size value in 2031 | USD 1735.36 million |
| Growth Rate | 9.5% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
Lymphedema Treatment Market Recent Development
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Lymphedema Treatment Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Lymphedema Treatment Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Lymphedema Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Lymphedema Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Lymphedema Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Lymphedema Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
